ArticlePloS one2025

Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens.

Christopher Alba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.